Pulmonx Corp
LUNG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001127537
In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pulmonx Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 4 filings
- 4 insiders, $177.0K in total
- Insiders trading
- 4
- Net value
- −$177.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pulmonx Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| French Glendon E. III | President and CEO | 1,137,936 | Sep 3, 2026 | 4 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | 316,994 | Sep 3, 2026 | 3 |
| Lehman David Aaron | General Counsel | 361,827 | Sep 3, 2026 | 4 |
| Rose Geoffrey Beran | Chief Commercial Officer | 449,832 | Sep 3, 2026 | 4 |
| Ferrari Richard M | Director | 127,024 | Jun 9, 2026 | 1 |
| Mead Dana G Jr. | Director | 139,714 | Jun 9, 2026 | 1 |
| Florin Daniel P | Director | 133,910 | Jun 9, 2026 | 2 |
| Burns Thomas William | Director | 113,399 | Jun 9, 2026 | 1 |
| Melenikiotou Georgia | Director | 139,714 | Jun 9, 2026 | 1 |
| Sullivan Tiffany | Director | 115,199 | Jun 9, 2026 | 1 |
| Sung Derrick | COO and CFO | 1,335,319 | Dec 3, 2025 | 1 |
| Williamson Steven S. | PRESIDENT AND CEO | 358,967 | Sep 3, 2025 | 0 |
| Joshi Mehul | Chief Financial Officer & PAO | 208,489 | Sep 3, 2025 | 0 |
| McKune John | INTERIM CFO | 76,210 | Mar 7, 2024 | 0 |
| Lynch Alissa Hsu | Director | 24,530 | Jun 2, 2023 | 0 |
| Boston Scientific Corp | 10% Owner | 1,488,106 | Jul 14, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2022 (view filing) | Jan 20-21 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $25.11 | −$627.7K | −2.2%1.09M after | 4 lots |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $31.05 | −$776.2K | −2.2%1.11M after | 2 lots |
| Dec 16, 2021 (view filing) | Dec 15 | 1 day | Rose Geoffrey BeranChief Commercial Officer | SSale | −22.0K | $30.55 | −$672.0K | −15.1%123.5K after | 2 lots |
| Dec 16, 2021 (view filing) | Dec 14-15 | 2 days | Sung DerrickChief Financial Officer | SSale | −6.00K | $31.71 | −$190.3K | −2.6%225.4K after | 3 lots |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | French Glendon E. IIIPresident and CEO | SSale | −1.42K | $32.73 | −$46.5K | −0.1%1.14M after | |
| Dec 3, 2021 (view filing) | May 20 | 197 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $41.95 | −$1.05M | −2.0%1.23M after | Amended2 lots |
| Dec 3, 2021 (view filing) | Apr 15 | 232 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $43.75 | −$1.09M | −2.0%1.25M after | Amended2 lots |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Lehman David AaronGeneral Counsel | SSale | −383 | $32.73 | −$12.5K | −2.2%16.8K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −355 | $32.73 | −$11.6K | −0.2%145.5K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Sung DerrickChief Financial Officer | SSale | −383 | $32.73 | −$12.5K | −0.2%231.4K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $35.98 | −$899.5K | −2.2%1.11M after | 4 lots |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Rose Geoffrey BeranChief Commercial Officer | SSale | −7.00K | $39.94 | −$279.6K | −4.6%145.8K after | |
| Oct 22, 2021 (view filing) | Oct 21 | 1 day | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $39.75 | −$993.7K | −2.2%1.13M after | 2 lots |
| Oct 18, 2021 (view filing) | Oct 15 | 3 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −7.00K | $39.44 | −$276.1K | −4.4%152.8K after | |
| Sep 21, 2021 (view filing) | Sep 20-21 | 1 day | Sung DerrickChief Financial Officer | SSale | −6.00K | $37.43 | −$224.6K | −2.5%231.8K after | 3 lots |
| Sep 20, 2021 (view filing) | Sep 16 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $38.86 | −$971.5K | −2.1%1.16M after | |
| Sep 20, 2021 (view filing) | Sep 20 | Same day | French Glendon E. IIIPresident and CEO | SSale | −23.6K | $37.36 | −$880.6K | −100.0%0 after | 2 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −7.00K | $38.12 | −$266.8K | −4.2%159.8K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Sung DerrickChief Financial Officer | SSale | −383 | $40.09 | −$15.4K | −0.2%237.8K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −355 | $40.09 | −$14.2K | −0.2%166.8K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Lehman David AaronGeneral Counsel | SSale | −383 | $40.09 | −$15.4K | −2.2%17.2K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | French Glendon E. IIIPresident and CEO | SSale | −1.42K | $40.09 | −$57.0K | −0.1%1.18M after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −1.00K | $36.59 | −$36.6K | −4.1%23.6K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $36.63 | −$915.8K | −2.1%1.18M after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −7.00K | $36.71 | −$257.0K | −4.0%166.9K after | |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Rose Geoffrey BeranChief Commercial Officer | SSale | −7.00K | $38.73 | −$271.1K | −3.9%173.9K after | 3 lots |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −25.0K | $38.73 | −$968.2K | −2.0%1.21M after | 3 lots |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | French Glendon E. IIIPresident and CEO | SSale | −1.00K | $38.70 | −$38.7K | −3.9%24.6K after | 3 lots |
| Jul 14, 2021 (view filing) | Jul 13 | 1 day | Boston Scientific Corp10% Owner | SSale | −2.50M | $37.45 | −$93.6M | −62.7%1.49M after | |
| Jul 13, 2021 (view filing) | Jul 12 | 1 day | Florin Daniel PDirector | PPurchase | +2.50K | $40.00 | +$100.0K | +49.7%7.53K after |